Management of Central Venous Catheters in Patients with Cancer and Candidemia
Citations Over TimeTop 10% of 2004 papers
Abstract
To determine the need and appropriate timing of catheter removal in patients with candidemia, the records for 404 patients with cancer and central venous catheters (CVCs) who developed candidemia during the period of 1993-1998 were retrospectively reviewed. Of the total 404 cases of candidemia, 241 (60%) were due to a primary source, 111 (27%) were catheter related, and 52 (13%) were secondary cases of candidemia caused by a source other than the catheter. Multivariate analysis showed that catheter removal < or =72 h after onset improved response to antifungal therapy exclusively in patients with catheter-related candidemia (P=.04). Clinical characteristics that suggested a noncatheter source for the candidemia were disseminated infection (P<.01), previous chemotherapy (P<.01), previous corticosteroid therapy (P=.02), and poor response to antifungal therapy (P<.03). CVC removal < or =72 h after onset should be considered in patients with suspected catheter-related candidemia who have no evidence of dissemination, recent corticosteroid therapy, or chemotherapy.
Related Papers
- Advances in research on antifungal effect of natural plant components(2011)
- Study on Antifungal Activity of Self-made Combined Antifungal Agent to Color-deterioration Transfer Coating Leather(2007)
- Study on the Development of Combined Antifungal Agents Used in the Leather Industry(I):Comparison of Antifungal Effect of Single Compound(2005)
- → ChemInform Abstract: 3‐Imidazolyl‐Substituted Flavans as Potential Antifungal Agents: Synthesis, Stereochemical Properties and Antifungal Activity.(2009)